Guggenheim Capital’s Enzo Biochem, Inc. ENZ Stock Holding History

Guggenheim Capital’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,790	Closed	-$65K	–	2641
2018 Q1	$65K	Buy	11,790 +269	+2%	+$1.9K	﹤0.01%	2690
2017 Q4	$93K	Sell	11,521 -1,810	-14%	-$17.3K	﹤0.01%	2607
2017 Q3	$139K	Buy	13,331 +52	+0.4%	+$577	﹤0.01%	2640
2017 Q2	$145K	Sell	13,279 -32	-0.2%	-$298	﹤0.01%	2671
2017 Q1	$110K	Buy	13,311 +8	+0.1%	+$56	﹤0.01%	2684
2016 Q4	$93K	Buy	13,303 +38	+0.3%	+$243	﹤0.01%	2771
2016 Q3	$68K	Buy	13,265 +8	+0.1%	+$48	﹤0.01%	2753
2016 Q2	$79K	Buy	13,257 +1,250	+10%	+$6.94K	﹤0.01%	2748
2016 Q1	$55K	Buy	12,007 +1,333	+12%	+$5.93K	﹤0.01%	2796
2015 Q4	$48K	Buy	+10,674	New	+$45.1K	﹤0.01%	2895
2015 Q2	–	Sell	-13,128	Closed	-$38K	–	3102
2015 Q1	$38K	Buy	13,128 +1,810	+16%	+$5.93K	﹤0.01%	2953
2014 Q4	$50K	Buy	+11,318	New	+$54K	﹤0.01%	2915
2014 Q3	–	Sell	-22,259	Closed	-$117K	–	3137
2014 Q2	$117K	Buy	22,259 +2,719	+14%	+$11.8K	﹤0.01%	2985
2014 Q1	$81K	Buy	19,540 +4,441	+29%	+$15.2K	﹤0.01%	3058
2013 Q4	$44K	Buy	15,099 +896	+6%	+$2.22K	﹤0.01%	3070
2013 Q3	$36K	Buy	14,203 +2,027	+17%	+$4.81K	﹤0.01%	2975
2013 Q2	$25K	Buy	+12,176	New	+$26.9K	﹤0.01%	2971

Other funds holding ENZ

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Guggenheim Capital's ENZ Position: Q2 2018 in Review

Guggenheim Capital sold out of Enzo Biochem, Inc. (ENZ) in Q2 2018, closing a stake of 11,790 shares — an estimated $65K sold.

Guggenheim Capital first reported a position in ENZ in Q2 2013 and held it in 17 quarters. The position peaked at $145K in Q2 2017. 97 funds tracked by Wall St. Rank hold ENZ as of Q2 2018.

Guggenheim Capital reported no remaining Enzo Biochem, Inc. position as of Q2 2018 after selling out during the quarter.
Guggenheim Capital sold 11,790 Enzo Biochem, Inc. shares in Q2 2018, an estimated $65K.
Guggenheim Capital first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 17 quarters.
Guggenheim Capital's Enzo Biochem, Inc. position peaked at $145K in Q2 2017.
97 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.